ProShare Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Buy |
+18,613
| New | +$26.4K | ﹤0.01% | 2051 |
|
|
2024
Q3 | – | Sell |
-13,701
| Closed | -$15.1K | – | 2066 |
|
|
2024
Q2 | $15.1K | Sell |
13,701
-3,749
| -21% | -$4.12K | ﹤0.01% | 1821 |
|
|
2024
Q1 | $21.6K | Buy |
17,450
+1,430
| +9% | +$1.77K | ﹤0.01% | 1970 |
|
|
2023
Q4 | $16.8K | Buy |
16,020
+2,361
| +17% | +$2.48K | ﹤0.01% | 1925 |
|
|
2023
Q3 | $93.6K | Buy |
13,659
+53
| +0.4% | +$363 | ﹤0.01% | 1645 |
|
|
2023
Q2 | $141K | Buy |
13,606
+1,378
| +11% | +$14.3K | ﹤0.01% | 1625 |
|
|
2023
Q1 | $98.9K | Sell |
12,228
-1,600
| -12% | -$12.9K | ﹤0.01% | 1592 |
|
|
2022
Q4 | $218K | Buy |
13,828
+1,098
| +9% | +$17.3K | ﹤0.01% | 1442 |
|
|
2022
Q3 | $201K | Buy |
12,730
+823
| +7% | +$13K | ﹤0.01% | 1408 |
|
|
2022
Q2 | $167K | Sell |
11,907
-3,998
| -25% | -$56.1K | ﹤0.01% | 1515 |
|
|
2022
Q1 | $274K | Sell |
15,905
-3,855
| -20% | -$66.4K | ﹤0.01% | 1688 |
|
|
2021
Q4 | $287K | Buy |
+19,760
| New | +$287K | ﹤0.01% | 1816 |
|
|
2021
Q3 | – | Sell |
-11,264
| Closed | -$198K | – | 2004 |
|
|
2021
Q2 | $198K | Buy |
+11,264
| New | +$198K | ﹤0.01% | 2150 |
|
|
2019
Q4 | – | Sell |
-14,710
| Closed | -$16K | – | 1790 |
|
|
2019
Q3 | $16K | Sell |
14,710
-1,088
| -7% | -$1.18K | ﹤0.01% | 1645 |
|
|
2019
Q2 | $35K | Sell |
15,798
-1,957
| -11% | -$4.34K | ﹤0.01% | 1588 |
|
|
2019
Q1 | $106K | Buy |
17,755
+148
| +0.8% | +$884 | ﹤0.01% | 1567 |
|
|
2018
Q4 | $130K | Buy |
17,607
+1,704
| +11% | +$12.6K | ﹤0.01% | 1439 |
|
|
2018
Q3 | $231K | Sell |
15,903
-607
| -4% | -$8.82K | ﹤0.01% | 1503 |
|
|
2018
Q2 | $330K | Sell |
16,510
-718
| -4% | -$14.4K | ﹤0.01% | 1325 |
|
|
2018
Q1 | $302K | Sell |
17,228
-2,837
| -14% | -$49.7K | ﹤0.01% | 1314 |
|
|
2017
Q4 | $495K | Buy |
+20,065
| New | +$495K | ﹤0.01% | 1137 |
|